Sign In
Buy AMED
$100.99
+0 (+0%)
At Close: Nov 13, 2025
Joel Greenblatt's Strategic Moves: A Closer Look at SPDR S&P 500 ETF Trust
05:03pm, Friday, 14'th Nov 2025
Insights from the Third Quarter 2025 13F Filing Joel Greenblatt (Trades, Portfolio) recently submitted the 13F filing for the third quarter of 2025, providing
Twilio Set to Join S&P MidCap 400
06:08pm, Thursday, 14'th Aug 2025
NEW YORK , Aug. 14, 2025 /PRNewswire/ -- Twilio Inc. (NYSE: TWLO) will replace Amedisys Inc. (NASD: AMED) in the S&P MidCap 400 effective prior to the opening of trading on Tuesday, August 19. S&P 500
Amedisys: Thoughts On UnitedHealth Merger, Plus Underlying Factors
11:32pm, Sunday, 03'rd Aug 2025
AMED's planned merger with UnitedHealth remains on the rocks with regulatory overhang still an issue. The deal is also asymmetrically weighted in UNH's favor, with the latter up for no penalty if it f
Amedisys (AMED) is a Top-Ranked Value Stock: Should You Buy?
10:41am, Friday, 01'st Aug 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Amedisys (AMED) Q2 Revenue Tops 5%
11:06pm, Wednesday, 30'th Jul 2025
Amedisys (AMED) Q2 Revenue Tops 5%
Here's What Key Metrics Tell Us About Amedisys (AMED) Q2 Earnings
08:31pm, Tuesday, 29'th Jul 2025
Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street
Amedisys (AMED) Beats Q2 Earnings and Revenue Estimates
06:55pm, Tuesday, 29'th Jul 2025
Amedisys (AMED) came out with quarterly earnings of $1.54 per share, beating the Zacks Consensus Estimate of $1.39 per share. This compares to earnings of $1.32 per share a year ago.
Amedisys Reports Second Quarter 2025 Financial Results
04:45pm, Tuesday, 29'th Jul 2025
BATON ROUGE, La., July 29, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2025.
Here's Why You Should Retain AMED Stock in Your Portfolio for Now
09:30am, Friday, 13'th Jun 2025
Amedisys' high Quality of Patient Care and Patient Satisfaction star ratings bring optimism to investors. Yet, a dull macroeconomic condition adds to the worry.
AMED or CHE: Which Is the Better Value Stock Right Now?
12:41pm, Friday, 23'rd May 2025
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Amedisys (AMED) and Chemed (CHE). But which of these two stocks offers value investors a better bang fo
Are Medical Stocks Lagging Amedisys (AMED) This Year?
10:45am, Friday, 23'rd May 2025
Here is how Amedisys (AMED) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
AMED Stock Trades Flat Despite Q1 Earnings Beat, Margins Rise
08:25am, Thursday, 24'th Apr 2025
Amedisys delivers first-quarter top-line growth across three of its segments, namely Home Health, Hospice and High Acuity Care.
Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics
09:30pm, Wednesday, 23'rd Apr 2025
Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street
Amedisys (AMED) Tops Q1 Earnings Estimates
06:55pm, Wednesday, 23'rd Apr 2025
Amedisys (AMED) came out with quarterly earnings of $1.25 per share, beating the Zacks Consensus Estimate of $1.13 per share. This compares to earnings of $1.03 per share a year ago.
Amedisys Reports First Quarter 2025 Financial Results
04:45pm, Wednesday, 23'rd Apr 2025
BATON ROUGE, La., April 23, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2025.
